2017
DOI: 10.1016/j.cgh.2017.06.051
|View full text |Cite
|
Sign up to set email alerts
|

Inflammatory Bowel Disease and Small Bowel Cancer Risk, Clinical Characteristics, and Histopathology: A Population-Based Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
68
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 62 publications
(70 citation statements)
references
References 48 publications
2
68
0
Order By: Relevance
“…Although incompletely understood, GI inflammation‐mediated progression to cancer development might involve bacterial toxin production, release of alarmins, gut biofilm modification, dysregulation of gut barrier function, suppression of anti‐inflammatory mediators and transition through an element of high grade dysplasia to cell damage and aneuploidy 13, 19, 35, 40, 60, 61, 62…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although incompletely understood, GI inflammation‐mediated progression to cancer development might involve bacterial toxin production, release of alarmins, gut biofilm modification, dysregulation of gut barrier function, suppression of anti‐inflammatory mediators and transition through an element of high grade dysplasia to cell damage and aneuploidy 13, 19, 35, 40, 60, 61, 62…”
Section: Discussionmentioning
confidence: 99%
“…; Fuso0664, Fusobacterium spp.. transition through an element of high grade dysplasia to cell damage and aneuploidy. 13,19,35,40,[60][61][62] Fusobacterium spp. is pro-inflammatory, exhibits adhesive and invasive properties via virulence factors (i.e., FadA, fusobacterium autotransporter protein 2 and fusobacterial outer membrane protein A), and promotes pro-oncogenic features which might contribute to accelerated tumor growth and tumor burden.…”
Section: Discussionmentioning
confidence: 99%
“…In contrast to intestinal metaplasia in the esophagus and stomach, small intestinal UACL has not been related to an increased cancer risk. Recent reports have, however, pointed to an increased cancer risk also in small intestinal CD and one report suggested a connection between UACL and CD enteritis‐associated small bowel adenocarcinoma .…”
Section: Introductionmentioning
confidence: 99%
“…On the other hand, SBC often localise in the inflamed ileum in CrD [2,8], a form of relapsing transmural inflammatory bowel disease due to an abnormal immune response to commensal microbiota [9]. Most CrD-SBC are microsatellite stable, have low TILs and often show a non-glandular histotype coupled with a non-intestinal phenotype [2,7,8,[10][11][12].…”
Section: Introductionmentioning
confidence: 99%
“…On the other hand, small bowel resection and use of salicylates for more than two years protect against SBC in patients with CrD. 25 As regards gender, the rates of female prevalence are extremely heterogeneous in both CD-SBC (25-62%) [2,5,5,20,21] and CrD-SBC (29-60%) [2,8,[10][11][12][22][23][24][25][26][27][28][29] so that it is hard to assess a gender predominance in either conditions. However, considering the strong prevalence of CD in women [4], these data may suggest that male gender is at higher risk to develop CD-SBC.…”
Section: Introductionmentioning
confidence: 99%